Roger Aston
Chairman at RESP HEAL
Net worth: 2 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brian Leedman | M | - | 11 years | |
| Paul Brennan | M | 63 | 2 years | |
| Jerry Kanellos | M | 61 | 9 years | |
| Darren M. Keamy | M | - | 19 years | |
| Tony Keating | M | - | 9 years | |
| Brenda Mary Shanahan | F | - | 17 years | |
| Nigel Lange | M | - | 4 years | |
| Philippe Wolgen | M | 61 | 19 years | |
| Ravi Savarirayan | M | 57 | 7 years | |
| Richard Mollard | M | - |
Pitney Pharmaceuticals Pty Ltd.
 Pitney Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of PharmAust Ltd., Pitney Pharmaceuticals Pty Ltd. provides medical and pharmaceutical services. The company is based in Kogarah, Australia. The CEO of the Australian company is Richard Mollard. Pitney Pharmaceuticals was acquired by PharmAust Ltd. on August 13, 2013 for $8.18 million. | - |
| Travis Robins | M | - | - | |
| Steven Lydeamore | M | 56 | 2 years | |
| Phillip Hains | M | 64 | 11 years | |
| David John Williams | M | 70 | 10 years | |
| Daniel Pollock | M | 64 | 12 years | |
| Lachlan Hay | M | - | 17 years | |
| Scott Savage | M | - | 3 years | |
| Al Rey Lunar | M | - | 4 years | |
| Mike Connell | M | - | 3 years | |
| Jamie Joint | F | - | - | |
| Joanne Casey | M | 47 | - | |
| Michael Stein | M | 60 | 4 years | |
| Paul Hopper | M | 68 |
Biolife Science Ltd.
 Biolife Science Ltd. Pharmaceuticals: OtherHealth Technology Part of Imugene Ltd., Biolife Science Ltd. is an Australian company that manufactures cancer therapeutic vaccines. The company is based in Brisbane, Australia. The company was founded by Brian Leedman. Biolife Science was acquired by Imugene Ltd. from Acuvax Ltd. on December 20, 2013 for $4.08 million. | - |
| Reza Moussakhani | M | - | 11 years | |
| Richard L. Faherty | M | 77 |
pSiMedica Ltd.
 pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | - |
| Nicola Farley | F | 45 | 12 years | |
| Christopher Ntoumenopoulos | M | - | 9 years | |
| David Turner | M | - | 3 years | |
| Flavio Palumbo | M | 50 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Nick Falzon | M | - | 4 years | |
| Craig Bottomley | M | - |
Halcygen Pharmaceuticals Ltd.
 Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 5 years |
| Aaron John Finlay | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 5 years |
| Bryant McLarty | M | - | 10 years | |
| Roger Corbett | M | 81 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | - |
| Yao Lee | M | 54 | 7 years | |
| Graeme Roy Kaufman | M | 74 | 6 years | |
| John Martin | M | 62 | 10 years | |
| Martin Frederick Rogers | M | 43 | - | |
| Stuart Mudge | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | - |
| David Parry | M | 70 |
The University of Manchester
| 7 years |
| Neil M. Frazer | M | 68 | 1 years | |
| Bruce Mathieson | M | 80 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 3 years |
| Ron Best | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 13 years |
| Ian Frank Scholes | M | 69 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 15 years |
| Chris Roberts | M | 70 | 5 years | |
| David J. Sparling | M | 52 | 9 years | |
| Elane Zelcer | M | - | 4 years | |
| David Morris | M | - | - | |
| Margaret Kay Taylor | F | 64 | - | |
| Amos Meltzer | M | 58 | - | |
| John Bird | M | - | - | |
| Grant Rawlin | M | - | 14 years | |
| Angelo Morella | M | - | - | |
| Peter Vaughan | M | 40 | 5 years | |
| Jillian McGregor | F | - | - | |
| Scott Richards | M | 60 | 10 years | |
| Stephen Anastasiou | M | 67 | 11 years | |
| Udantha Abeyratne | M | - | 5 years | |
| Ben Herbert | M | 56 | 7 years | |
| Thomas Liquard | M | 51 | 2 years | |
| Daniel Kenny | M | - | 6 years | |
| Beverley June Hughes | F | 74 |
The University of Manchester
| 21 years |
| Peter Anastasiou | M | 63 | 6 years | |
| Okechukwu John Mbonu | M | 71 |
The University of Manchester
| 8 years |
| Dan Peres | M | - | 3 years | |
| Steven Swinson | M | - |
The University of Manchester
| 4 years |
| Karl Pechmann | M | - | 3 years | |
| Martin Cross | M | - | 5 years | |
| Panos Andreas Loizou | M | 60 |
The University of Manchester
| 7 years |
| Richard Berman | M | 81 | 1 years | |
| Robert Johnston | M | - | 6 years | |
| Philip Powell | M | 65 | 6 years | |
| Lawrence John Wood | M | 87 | 6 years | |
| Alan Dunton | M | 70 | 2 years | |
| Otto Buttula | M | - | 2 years | |
| Gary Jacob | M | 77 | 2 years | |
| Geoffrey Norman Vaughan | M | 91 | 15 years | |
| Stewart Washer | M | 54 | 1 years | |
| Richard H. Irving | M | - |
The University of Manchester
| 6 years |
| Andrew Burgess | M | 55 |
Ascent Pharmahealth Pty Ltd.
 Ascent Pharmahealth Pty Ltd. Pharmaceuticals: MajorHealth Technology Ascent Pharmahealth Pty Ltd. manufactures and supplies generic pharmaceuticals. It offers skincare, private prescription medicine, and dermorganics. The company was founded by Dennis Bastas in December 2003 and is headquartered in Australia. | - |
| Simon O'Loughlin | M | 66 | 1 years | |
| Fung Man Wai | M | 75 |
The University of Manchester
| 4 years |
| John Chiplin | M | 66 | 3 years | |
| Wayne Best | M | - | 4 years | |
| Adam James Sierakowski | M | - | 3 years | |
| Graeme N. Stevens | M | - | 6 years | |
| Henry Gulev | M | - | 6 years | |
| Robyn Elliott | M | 63 | 18 years | |
| Glen Richards | M | - | 5 years | |
| Joseph M. Baini | M | 58 | 2 years | |
| Lawrence Gozlan | M | 45 | 1 years | |
| Paul MacLeman | M | 58 | 4 years | |
| Mark Cansdale | M | - | 6 years | |
| Tom Milicevic | M | - | 4 years | |
| David Franklyn | M | 60 | 4 years | |
| Wai Ching Wong | F | 63 |
The University of Manchester
| 5 years |
| Karen Guerra | F | 68 |
The University of Manchester
| 3 years |
| Kwai Wing Lai | M | 62 |
The University of Manchester
| 4 years |
| Neoclis Nicolaou | M | 64 |
The University of Manchester
| 4 years |
| Barry Green | M | - |
The University of Manchester
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Australia | 87 | 87.00% |
| United Kingdom | 13 | 13.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Roger Aston
- Personal Network
